|1.||Walls, Michael A: 1 article (05/2004)|
|2.||Hall, Mary A: 1 article (05/2004)|
|3.||Dale, James B: 1 article (05/2004)|
|4.||Stroop, Steven D: 1 article (05/2004)|
|5.||Reddish, Mark A: 1 article (05/2004)|
|6.||Lowell, George H: 1 article (05/2004)|
|7.||Hu, Mary C: 1 article (05/2004)|
|8.||Burt, David S: 1 article (05/2004)|
05/01/2004 - "Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections."
10/15/1988 - "The present studies were undertaken to determine the pathogenicity of group A streptococci introduced intranasally (i.n.) into mice in an attempt to mimic mucosal infections in humans and to determine the efficacy of streptococcal vaccines administered via the mucosal route. "
|2.||Rheumatic Heart Disease (Rheumatic Heart Diseases)
|3.||Rheumatic Fever (Acute Articular Rheumatism)
12/01/1992 - "Streptococcal research will help not only in improving the quality of primary prevention of rheumatic fever, but also in developing streptococcal vaccines."
08/01/1991 - "This recognition of a B cell marker unique to individuals with rheumatic fever has important public health implications with respect to identification of individuals susceptible to rheumatic fever, possible prevention of disease and the recognition of prime candidates for future streptococcal vaccines."
05/01/1980 - "Streptococcal vaccines and global strategies for prevention of rheumatic fever."
|4.||Streptococcal Infections (Streptococcal Infection)
09/15/1995 - "If group B streptococcal vaccines being developed for prevention of neonatal disease are protective in adults, a vaccination strategy targeting those at highest risk has the potential to substantially reduce the burden of invasive group B streptococcal infection in adults."
10/15/1988 - "Our data suggest that streptococcal vaccines administered locally evoke protective immunity against streptococcal infections."